We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTA icon
151
Establishment Labs
ESTA
$2.28B
$923K 0.15%
24,511
+71
+0.3% +$1.87K
PPLI
152
People Inc
PPLI
$3.1B
$919K 0.15%
+8,890
New +$681K
TRTN
153
DELISTED
Triton International Limited
TRTN
$916K 0.15%
18,883
-1,319
-7% -$55.8K
UBER icon
154
Uber
UBER
$153B
$913K 0.15%
+17,895
New +$802K
MMSI icon
155
Merit Medical Systems
MMSI
$5.32B
$909K 0.15%
+16,378
New +$845K
TALO icon
156
Talos Energy
TALO
$2.4B
$908K 0.15%
110,212
+10,666
+11% +$83K
ZM icon
157
Zoom
ZM
$30.6B
$908K 0.15%
2,693
+1,582
+142% +$705K
GEL icon
158
Genesis Energy
GEL
$1.85B
$906K 0.15%
+145,971
New +$829K
CNCE
159
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$905K 0.15%
71,627
+13,532
+23% +$154K
F icon
160
Ford
F
$55.7B
$902K 0.15%
102,573
+44,447
+76% +$372K
BCPC
161
Balchem Corp
BCPC
$5.72B
$901K 0.15%
7,820
+4,538
+138% +$479K
JYNT icon
162
The Joint Corp
JYNT
$119M
$900K 0.15%
34,284
+15,943
+87% +$365K
OII icon
163
Oceaneering
OII
$4.77B
$898K 0.15%
112,993
-248,203
-69% -$1.45M
GDEN
164
DELISTED
Golden Entertainment
GDEN
$895K 0.15%
45,013
-4,824
-10% -$77.5K
XIFR
165
XPLR Infrastructure LP
XIFR
$1.08B
$895K 0.15%
13,352
-15,122
-53% -$975K
MCD icon
166
McDonald's
MCD
$195B
$894K 0.15%
4,165
-2,262
-35% -$492K
EPAY
167
DELISTED
Bottomline Technologies Inc
EPAY
$888K 0.15%
16,832
-4,295
-20% -$195K
VSH icon
168
Vishay Intertechnology
VSH
$5.43B
$881K 0.14%
42,546
+11,924
+39% +$220K
ECOL
169
DELISTED
US Ecology, Inc.
ECOL
$881K 0.14%
24,258
-319
-1% -$11.1K
CBAY
170
DELISTED
Cymabay Therapeutics
CBAY
$877K 0.14%
+152,797
New +$1.16M
NVT icon
171
nVent Electric
NVT
$26.7B
$869K 0.14%
+37,315
New +$786K
LMNX
172
DELISTED
Luminex Corp
LMNX
$869K 0.14%
+37,573
New +$873K
OMCL icon
173
Omnicell
OMCL
$1.68B
$862K 0.14%
7,180
+3,472
+94% +$341K
RYN icon
174
Rayonier
RYN
$6.55B
$861K 0.14%
32,311
-7,882
-20% -$201K
WLKP icon
175
Westlake Chemical Partners
WLKP
$763M
$854K 0.14%
35,826
+20,894
+140% +$424K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.